Sign inGet started

VLON

Vallon Pharmaceuticals, Inc.CIK 1824293 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
9

AI insights for VLON PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for VLON
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Thorell MarellaDirector4$0$02022-12-13
Ammer RichardDirector4$0$02022-06-09
Payne Joseph EDirector5$71.8K$02022-06-09
Chhabra MeenuDirector1$0$02022-02-23
Baker David CharlesChief Executive Officer4$8.0K$02022-02-15
Kelly Leanne M.Chief Financial Officer5$25.2K$02022-02-15
Levi OfirDirector2$0$02021-05-14
Toren PennySVP, Regul Affairs & Prog Mgmt1$0$02021-05-14
SALMON Pharma GmbH10% Owner1$0$02021-02-12

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Thorell MarellaDirector J Other2022-12-132022-12-1528,517— $09,506SEC↗
Thorell MarellaDirector A Award2022-07-012022-07-0638,023— $038,023SEC↗
Thorell MarellaDirector A Award deriv2022-06-092022-06-107,500— $07,500SEC↗
Payne Joseph EDirector A Award deriv2022-06-092022-06-107,500— $07,500SEC↗
Ammer RichardDirector A Award deriv2022-06-092022-06-107,500— $07,500SEC↗
Chhabra MeenuDirector A Award deriv2022-02-232022-03-0915,000$7.67 $115.0K15,000SEC↗
Kelly Leanne M.Chief Financial Officer A Award deriv2022-02-152022-03-0150,000$5.63 $281.5K50,000SEC↗
Baker David CharlesChief Executive Officer A Award deriv2022-02-152022-03-0161,000$5.63 $343.4K61,000SEC↗
Kelly Leanne M.Chief Financial Officer P Buy2021-06-042021-06-041,508$4.08 $6.2K6,250SEC↗
Kelly Leanne M.Chief Financial Officer P Buy2021-06-032021-06-041,085$4.05 $4.4K4,742SEC↗
Kelly Leanne M.Chief Financial Officer P Buy2021-06-022021-06-043,657$4.00 $14.6K3,657SEC↗
Payne Joseph EDirector P Buy2021-05-262021-05-276,800$4.50 $30.6K17,500SEC↗
Payne Joseph EDirector P Buy2021-05-252021-05-2710,700$3.85 $41.2K10,700SEC↗
Baker David CharlesChief Executive Officer A Award deriv2021-05-142021-05-18100,000— $0100,000SEC↗
Toren PennySVP, Regul Affairs & Prog Mg A Award deriv2021-05-142021-05-1825,000— $025,000SEC↗
Kelly Leanne M.Chief Financial Officer A Award deriv2021-05-142021-05-1870,000— $070,000SEC↗
Levi OfirDirector A Award deriv2021-05-142021-05-1830,000— $030,000SEC↗
Levi OfirDirector A Award deriv2021-05-142021-05-1815,000— $015,000SEC↗
Ammer RichardDirector A Award deriv2021-05-142021-05-1810,204— $010,204SEC↗
Ammer RichardDirector A Award deriv2021-05-142021-05-1815,000— $015,000SEC↗
Payne Joseph EDirector A Award deriv2021-05-142021-05-1815,000— $015,000SEC↗
Payne Joseph EDirector A Award deriv2021-05-142021-05-1814,286— $014,286SEC↗
Thorell MarellaDirector A Award deriv2021-02-122021-02-1215,000— $015,000SEC↗
Baker David CharlesChief Executive Officer J Other2021-02-122021-02-127,843$6.40 $50.2K7,843SEC↗
Baker David CharlesChief Executive Officer P Buy2021-02-122021-02-121,000$8.00 $8.0K8,843SEC↗
SALMON Pharma GmbH10% Owner J Other2021-02-122021-02-1247,063$6.40 $301.2K47,063SEC↗
Ammer RichardDirector J Other2021-02-122021-02-1247,063$6.40 $301.2K47,063SEC↗